Replication-Competent Viruses as Cancer Immunotherapeutics: …
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4968310/
WEBAug 1, 2015 · Replication-competent (oncolytic) viruses (OV) are not similarly limited to certain indications, as they can, via oncolysis, release the unique tumor epitopes from each patient's own tumor and can, therefore, be considered as in situ vaccines. Development of OVs has earlier been focusing on enhancing replication, lytic cell death, and systemic ...
DA: 28 PA: 38 MOZ Rank: 54